Acute myeloid leukemia immune escape by epigenetic CD48 silencing. (29th January 2020)

• Record Type: Journal Article
• Authors: Wang, Zhiding; Xiao, Yang; Guan, Wei; Wang, Mengzhen; Chen, Jinghong; Zhang, Linlin; Li, Yan; Xiong, Qian; Wang, Hong; Wang, Maoquan; Li, Yuyan; Lv, Na; Li, Yonghui; Wang, Lixin; Yu, Li
• Is Part Of: Clinical science. Volume 134:Number 2(2020)
• Page Start: 261
• Page End: 271
• Publication Date: 2020-01-29
• Subjects: AML -- CD48 -- Methylation -- NK; Medicine -- Periodicals; Biochemistry -- Periodicals; 616
• DOI: 10.1042/CS20191170
• Languages: English
• ISSNs: 0143-5221

Abstract

Abstract: Acute myeloid leukemia (AML) is a malignant disorder of hemopoietic stem cells. AML can escape immunosurveillance of natural killer (NK) by gene mutation, fusions and epigenetic modification. The mechanism of AML immune evasion is not clearly understood. Here we show that CD48 high expression is a favorable prognosis factor that is down-regulated in AML patients, which can help AML evade from NK cell recognition and killing. Furthermore, we demonstrate that CD48 expression is regulated by methylation and that a hypomethylating agent can increase the CD48 expression, which increases the NK cells killing in vitro . Finally, we show that CD48 high expression can reverse the AML immune evasion and activate NK cells function in vivo . The present study suggests that a combination the hypomethylating agent and NK cell infusion could be a new strategy to cure AML.